The Heterogeneity of Type 1 Diabetes: Implications for Pathogenesis, Prevention, and Treatment-2024 Diabetes, Diabetes Care, and Diabetologia Expert Forum [0.03%]
1型糖尿病的异质性：对发病机制、预防和治疗的影响——2024年《糖尿病》、《糖尿病护理》与《糖尿病学》专家论坛
Carmella Evans-Molina,Yuval Dor,Åke Lernmark et al.
Carmella Evans-Molina et al.
This article summarizes the current understanding of the heterogeneity of type 1 diabetes from a June 2024 international Expert Forum organized by the editors of Diabetes, Diabetes Care, and Diabetologia. The Forum reviewed key factors cont...
Clinical and Demographic Characteristics Associated With Diabetes Remission in Six Integrated Health Care Systems: A Retrospective Cohort Study [0.03%]
六项综合医疗体系中糖尿病缓解的临床和人口统计特征：一项回顾性队列研究
Barune Thapa,Julie A Schmittdiel,David Arterburn et al.
Barune Thapa et al.
Objective: To assess the real-world frequency and characteristics associated with type 2 diabetes remission in a large and diverse cohort of U.S. adults. ...
Extinguishing the Fire: Treating Pediatric Type 2 Diabetes by Targeting Obesity Treatment [0.03%]
对儿童2型糖尿病进行肥胖治疗以改善病情
Megan O Bensignor,Daniel S Hsia,Michelle A Van Name et al.
Megan O Bensignor et al.
Childhood obesity affects nearly one in five children in the U.S. and is a key driver in youth-onset type 2 diabetes (T2D) development and progression. Effective obesity treatment may lead to T2D remission and can greatly improve dysglycemi...
Real-Time Continuous Glucose Monitoring in Pregnancies With Gestational Diabetes: A Randomized Controlled Trial [0.03%]
妊娠期糖尿病孕产妇实时动态血糖监测的随机对照试验
Amy M Valent,Michaela Rickert,Christian Huerta Pagan et al.
Amy M Valent et al.
Objective: To compare the efficacy of real-time continuous glucose monitoring (CGM; intervention) with capillary blood glucose (CBG) monitoring (control) alone to achieve greater percent glucose time in range (%TIR) among...
Effects of Semaglutide With or Without Concomitant Mineralocorticoid Receptor Antagonist Use in Participants With Type 2 Diabetes and Chronic Kidney Disease: A FLOW Trial Prespecified Secondary Analysis [0.03%]
索马鲁肽单用或联用盐皮质激素受体拮抗剂在2型糖尿病及慢性肾脏病患者中的疗效和安全性：FLOW试验的预设次级分析
Peter Rossing,George Bakris,Vlado Perkovic et al.
Peter Rossing et al.
Objective: In the Evaluate Renal Function With Semaglutide Once Weekly (FLOW) trial, semaglutide reduced the risk of major kidney and cardiovascular (CV) outcomes and all-cause mortality in people with type 2 diabetes (T2...
A Metabolomics Study of Cardiac Dysfunction in Hyperglycemia-Findings From the Atherosclerosis Risk in Communities (ARIC) Study and the Hispanic Community Health Study/Study of Latinos (HCHS/SOL) [0.03%]
高血糖的心脏功能障碍代谢组学研究——来自社区动脉粥样硬化风险(ARIC)研究和拉丁裔健康社区研究/拉丁裔研究(HCHS/SOL)的发现
Yilin Yoshida,Ngoc Quynh Nguyen,Eun Hye Moon et al.
Yilin Yoshida et al.
Objective: Hyperglycemic states (prediabetes and diabetes) are associated with heart failure (HF) risk. We aimed to identify distinct metabolites for subclinical cardiac dysfunction, a precursor of HF, in hyperglycemic or...
DNA Methylation Smoking Scores and Risk of Islet Autoimmunity and Type 1 Diabetes [0.03%]
DNA甲基化与吸烟计分及自身免疫和1型糖尿病风险的关系
Lauren A Vanderlinden,Ellen Wong,Randi K Johnson et al.
Lauren A Vanderlinden et al.
Objective: Multiple studies have reported an inverse association between self-reported smoking during pregnancy and offspring type 1 diabetes (T1D) risk. We investigated the association between DNA methylation (DNAm) smok...
Evaluation of a Prediction-Based Bedtime Intervention in Reducing Nocturnal Low Glucose in Adults With Type 1 Diabetes: The DailyDose Bedtime Smart Snack Crossover Study [0.03%]
基于预测的 bedtime 干预减少成人 1 型糖尿病夜间低血糖事件的有效性评估：DailyDose bedtime 智能小吃交叉研究
Clara Mosquera-Lopez,Valentina Roquemen-Echeverri,Peter G Jacobs et al.
Clara Mosquera-Lopez et al.
Objective: Nocturnal hypoglycemia is challenging for individuals with type 1 diabetes, particularly those who are physically active or using multiple daily injections (MDIs). We hypothesized that adding bedtime decision s...
Contrasting Adult and Pediatric Populations in a Cohort of At-Risk Relatives in The T1D TrialNet Pathway to Prevention Study [0.03%]
1型糖尿病TrialNet预防途径研究中高危亲属队列的成人和儿童群体的对比研究结果
Erin L Templeman,Lauric A Ferrat,Nicholas Thomas et al.
Erin L Templeman et al.
Objective: More than half of incident type 1 diabetes (T1D) occurs in adults, yet research on disease progression predominantly focuses on at-risk children. We compared autoantibody screening outcomes and T1D progression ...
SCORE2-Diabetes Predicts the Risk of Heart Failure and Atrial Fibrillation in Individuals With Newly Diagnosed Type 2 Diabetes [0.03%]
新诊断的2型糖尿病患者的 SCORE2-Diabetes 模型可预测心力衰竭和房颤的风险
Stelios Karayiannides,Natalia Widén,Georgios Tsatsaris et al.
Stelios Karayiannides et al.